NAD and mitochondrial function

Medically reviewed by Hemal Patel, PhD, Professor of Anesthesiology at UC San Diego School of Medicine. UCSD profile.

NAD has become the sort of supplement topic that attracts equal parts serious science and expensive wishful thinking. The serious part is worth understanding. Nicotinamide adenine dinucleotide, NAD, is central to cellular energy metabolism, redox reactions, and the activity of enzymes such as sirtuins and PARPs. The wishful part starts when every age-related complaint gets folded into a sales pitch for NMN or NR and the phrase ‘cellular rejuvenation’ is wheeled out like a magician's scarf.

The useful question is narrower. Does supporting NAD status plausibly matter for mitochondrial function, and if so, what does the human evidence actually show? In short, yes, the mechanism matters. No, the evidence is not strong enough to justify treating NAD precursors as a miracle. This article sits inside MeScreen's mitochondrial health and cellular energy UK hubs because NAD belongs in that broader system, not in an isolated supplement fantasy.

What NAD actually does

NAD is a coenzyme involved in oxidation-reduction reactions. In plainer English, it helps shuttle electrons during metabolic processes that generate ATP. That puts it close to glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation. Without adequate NAD availability, the machinery involved in energy production becomes less efficient.

NAD also matters beyond ATP production. It acts as a substrate for sirtuins, which are linked to stress responses and mitochondrial adaptation, and for PARPs, which are involved in DNA repair. This is one reason NAD gets discussed in ageing research. Cells rely on it for several housekeeping tasks that become more relevant when stress load rises.

Why NAD matters for mitochondria

Mitochondria depend on a constant flow of reducing equivalents to keep the electron transport chain running. NADH, the reduced form of NAD, feeds electrons into complex I. If that sounds technical, the practical version is straightforward, NAD is part of the supply chain that lets mitochondria turn fuel into usable energy.

Animal and mechanistic studies suggest declining NAD availability may contribute to age-related reductions in mitochondrial function, impaired mitophagy, and lower metabolic resilience. That is biologically interesting. It is not yet the same as proving that taking a precursor will reliably restore those functions in ordinary humans living ordinary lives.

NMN and NR, the main supplement routes

The two best-known NAD precursors in the supplement world are nicotinamide mononucleotide, NMN, and nicotinamide riboside, NR. Both are marketed as ways to raise NAD levels indirectly. The marketing story is elegant. The human evidence is more mixed.

Some trials show NR can raise blood NAD metabolites. A few small human studies report modest effects on specific outcomes, but the evidence is inconsistent on whether that translates into clear improvements in strength, endurance, fatigue, cognition, or healthy ageing markers. NMN data are also emerging, with some trials showing signals around insulin sensitivity or metabolic parameters, but again the story is not settled.

Where the evidence is strongest

The strongest case for NAD-related support is still mechanistic and preclinical rather than broadly clinical. Researchers are interested because ageing, metabolic stress, and inflammation may reduce cellular NAD availability. Restoring that pool could plausibly support mitochondrial function, especially in contexts of higher stress or age-related decline.

But if the clinical question is, ‘Should a generally healthy UK adult with vague fatigue assume NR or NMN will fix the problem?’, the answer is no. Fatigue remains multi-causal. Sleep, glucose control, iron status, inflammation, thyroid issues, training load, mood, and broader biomarker patterns usually deserve attention first.

Where the hype runs ahead of the data

NAD supplements are often sold as if one pathway explains modern ageing, brain fog, and low drive in full. That is not how physiology works. Mitochondria live inside systems. If someone sleeps badly, eats chaotically, never trains, and carries clear metabolic dysfunction, adding a precursor rarely changes the wider terrain enough to matter.

There is also a common bait-and-switch in this market. A company cites compelling mechanistic work or animal research, then presents the supplement as if the human endpoint has already been proved. It often has not. Some interesting studies, yes. A mature consensus, no.

Who might reasonably consider it

NAD support may be a reasonable discussion point for people focused on healthy ageing, mitochondrial resilience, heavy training loads, or recovery, especially when the fundamentals are already in place. It belongs more naturally in the ‘possible refinement’ category than in the ‘obvious first move’ category.

That is why it pairs well with broader articles like mitochondrial supplements, what works? and CoQ10 and mitochondria. If someone is building a rational plan, they should compare supplement options rather than falling in love with the first clever acronym they meet.

Why testing still matters

One of the easiest mistakes in this space is trying to supplement around uncertainty instead of reducing the uncertainty. If fatigue, poor recovery, or lower resilience are the real issues, focused testing and biomarker context may be more valuable than buying another expensive bottle and hoping for spiritual ATP.

Mescreen's approach sits in that more sober middle ground. Better information first, then targeted decisions. That is especially true because NAD-related supplementation does not replace assessment of mitochondrial function, metabolic health, inflammation, or related biomarkers.

How this fits the UK reality

In the UK, many adults live in the gap between routine medical care and proactive optimisation. They are not acutely ill, but they do not feel well either. That gap is exactly where supplement marketing becomes aggressive. NAD products often sound as if they fill it completely. They do not. They may help in selected cases, but they are one possible tool inside a much larger strategy.

Bottom line

NAD matters deeply to mitochondrial function and cellular energy. That part is not in dispute. What remains in dispute is how much benefit most people can expect from NAD precursors in real-world settings. For now, the fairest verdict is that the mechanism is strong, the human evidence is interesting but incomplete, and the supplement belongs after basics and testing, not before them.

References

1. Yoshino J, Baur JA, Imai SI. NAD+ intermediates, the biology and therapeutic potential of NMN and NR. Cell Metabolism.
2. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology.
3. Conze D, et al. Safety and metabolism of long-term nicotinamide riboside supplementation in humans. Nature Communications.
4. Canto C, Auwerx J. NAD+ as a signalling molecule modulating metabolism. Cold Spring Harbor Perspectives in Medicine.